MarieAnne Tawil - Sumitomo Dainippon Director
DPM Stock | EUR 3.00 0.18 1.64% |
Director
Ms. MarieAnne Tawil is an Independent Director of the Company. Ms. Tawil has over 30 years of legal experience, principally in corporate, commercial and securities law, and over 20 years of management experience. She practiced law with Stikeman Elliott and McCarthy Tetrault and, in 1984, joined Quebecor Inc. as Legal Counsel, and also served as Corporationrationrate Secretary from 1987 until 1990. She was previously Chair of the board of Socit de lAssurance Automobile du Qubec, joined the board of Hydro Quebec in 2005 and, is also on the board of Stornoway Diamonds Corporation since 2015.
Age | 57 |
Tenure | 9 years |
Professional Marks | MBA |
Phone | 81 6 6203 5321 |
Web | https://www.sumitomo-pharma.com |
Sumitomo Dainippon Management Efficiency
Sumitomo Dainippon's management efficiency ratios could be used to measure how well Sumitomo Dainippon manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 243.96 B in total debt with debt to equity ratio (D/E) of 6.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sumitomo Dainippon Pharma has a current ratio of 1.85, which is within standard range for the sector. Debt can assist Sumitomo Dainippon until it has trouble settling it off, either with new capital or with free cash flow. So, Sumitomo Dainippon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sumitomo Dainippon Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sumitomo to invest in growth at high rates of return. When we think about Sumitomo Dainippon's use of debt, we should always consider it together with cash and equity.
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. SUMITOMO DAINIPPON operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6140 people. Sumitomo Dainippon Pharma (DPM) is traded on Frankfurt Exchange in Germany and employs 6,987 people. Management Performance
Return On Equity | -0.0399 | |||
Return On Asset | -0.0075 |
Sumitomo Dainippon Pharma Leadership Team
Elected by the shareholders, the Sumitomo Dainippon's board of directors comprises two types of representatives: Sumitomo Dainippon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo Dainippon's management team and ensure that shareholders' interests are well served. Sumitomo Dainippon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo Dainippon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter Nixon, Independent Director | ||
Richard Gosse, Vice President - Exploration | ||
Theophile Yameogo, Vice President - Digital Innovation | ||
Colin McAnuff, Treasurer | ||
Takuya Taguchi, Sr Unit | ||
Kelly StarkAnderson, Vice President - Legal and Corporate Secretary | ||
Hideyuki Harada, Mfg Div | ||
Richard Howes, COO, Executive Vice President | ||
Garth MacRae, Independent Director | ||
Hiroyuki Baba, Legal Design | ||
Toru Kimura, Regenerative Strategy | ||
Zebra Kasete, Vice President and Managing Director of Dundee Precious Metals Tsumeb | ||
Donald Young, Independent Director | ||
Lori Beak, Senior Vice President - Investor & Regulatory Affairs,Corporate Secretary | ||
Jeremy Kinsman, Independent Director | ||
Brent Johnson, Vice President - Environment | ||
Paul Proulx, Senior Vice President - Corporate Services | ||
Nikolay Hristov, Senior Vice President - Sustainable Business Development | ||
Hratch Jabrayan, Vice President General Manager - Dundee Precious Metals Kapan CJSC | ||
Jonathan Goodman, President CEO, Non-Independent Director | ||
Yoshiharu Ikeda, Modality Cancer | ||
John Lindsay, Senior Vice President - Projects | ||
Mark Crawley, Vice President - Commercial Affairs | ||
Peter Gillin, Lead Independent Director | ||
MarieAnne Tawil, Director | ||
Naoki Noguchi, Corp Governance | ||
Hisayoshi Kashima, Sr Controller | ||
Hume Kyle, CFO, Executive Vice President | ||
Anthony Walsh, Independent Director | ||
Juanita Montalvo, Director | ||
David Rae, Senior Vice President - Operations | ||
Hiroshi Nomura, Pres CEO | ||
Michael Dorfman, Senior Vice President - Corporate Development | ||
Atsuko Higuchi, Corp Affairs | ||
Shigeyuki Nishinaka, Sr Director | ||
Murray John, Independent Director |
Sumitomo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sumitomo Dainippon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0399 | |||
Return On Asset | -0.0075 | |||
Profit Margin | (0.01) % | |||
Operating Margin | (0.03) % | |||
Current Valuation | 2.7 B | |||
Shares Outstanding | 397.29 M | |||
Shares Owned By Insiders | 58.59 % | |||
Shares Owned By Institutions | 19.62 % | |||
Price To Earning | 15.44 X | |||
Price To Book | 0.64 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sumitomo Dainippon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sumitomo Dainippon's short interest history, or implied volatility extrapolated from Sumitomo Dainippon options trading.
Pair Trading with Sumitomo Dainippon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sumitomo Dainippon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will appreciate offsetting losses from the drop in the long position's value.Moving against Sumitomo Stock
0.56 | E908 | Lyxor 1 | PairCorr |
0.51 | LIE | Sun Life Financial | PairCorr |
0.5 | VP3 | VIETNAM ENTERPRISE INV | PairCorr |
The ability to find closely correlated positions to Sumitomo Dainippon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sumitomo Dainippon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sumitomo Dainippon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sumitomo Dainippon Pharma to buy it.
The correlation of Sumitomo Dainippon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sumitomo Dainippon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sumitomo Dainippon Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sumitomo Dainippon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Sumitomo Dainippon Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Sumitomo Stock analysis
When running Sumitomo Dainippon's price analysis, check to measure Sumitomo Dainippon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Dainippon is operating at the current time. Most of Sumitomo Dainippon's value examination focuses on studying past and present price action to predict the probability of Sumitomo Dainippon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Dainippon's price. Additionally, you may evaluate how the addition of Sumitomo Dainippon to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies |